{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:29:59Z","timestamp":1775302199870,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.carrev.2009.07.005","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T04:26:28Z","timestamp":1262838388000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Day 1 care in patients with non-ST-segment elevation myocardial infarction"],"prefix":"10.1016","volume":"11","author":[{"given":"Deepak","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2009.07.005_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib2","series-title":"Braunwald's heart disease: a textbook of cardiovascular medicine","author":"Libby","year":"2007"},{"key":"10.1016\/j.carrev.2009.07.005_bib3","first-page":"S430","article-title":"Burden of disease: medical and economic impact of acute coronary syndromes","volume":"12","author":"Turpie","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.carrev.2009.07.005_bib4","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early ACS versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-131-12-199912210-00011","article-title":"Ruptured plaques and leaking cells: cost-effectiveness in the diagnosis of acute coronary syndromes","volume":"131","author":"Fox","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2009.07.005_bib7","first-page":"596","article-title":"ACC\/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction","volume":"118","author":"Krumholz","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2009.07.005_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","article-title":"Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs","volume":"69","author":"Reilly","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.carrev.2009.07.005_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0002-9149(89)90857-6","article-title":"Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study)","volume":"64","author":"Rouan","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-8703(89)90742-4","article-title":"Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery","volume":"117","author":"de Zwaan","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2009.07.005_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia","volume":"335","author":"Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib15","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yuuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib19","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels","volume":"340","author":"Hamm","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Platelet Receptor Inhibition in Ischemic Syndrome Management. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2009.07.005_bib21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0735-1097(96)00447-0","article-title":"Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection","volume":"29","author":"Lindahl","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia","volume":"89","author":"TIMI IIIB Investigators","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-6143.2003.08062.x","article-title":"Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport trials","volume":"16","author":"Ellis","year":"2003","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2009.07.005_bib31","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2009.07.005_bib47","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2008.07.026","volume":"156","author":"Mehta","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2009.07.005_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehm562","article-title":"One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial","volume":"29","author":"Ndrepepa","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2009.07.005_bib35","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"The GUSTO investigators","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.103.5.658","article-title":"Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris","volume":"103","author":"Collet","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib40","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib41","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2009.07.005_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2006.04.029","article-title":"Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery","volume":"48","author":"Mehta","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.85.2.407","article-title":"The effects of acute and chronic cocaine use on the heart","volume":"85","author":"Kloner RA Hale","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2009.07.005_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9343(93)90212-8","article-title":"Influence of labetalol on cocaine-induced coronary vasoconstriction in humans","volume":"94","author":"Boehrer","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2009.07.005_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jacc.2008.10.005","article-title":"ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC 2009 appropriateness criteria for coronary revascularization","volume":"53","author":"Patel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2009.07.005_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2009.205","article-title":"Scientific evidence underlying the ACC\/AHA clinical practice guidelines","volume":"301","author":"Tricoci","year":"2009","journal-title":"JAMA"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838909002462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838909002462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:06:12Z","timestamp":1761559572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838909002462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1553838909002462"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2009.07.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Day 1 care in patients with non-ST-segment elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2009.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}